Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT01636141 Completed - Healthy Volunteers Clinical Trials

Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects

Start date: June 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if OLT1177 Gel is safe and can be tolerated when given as a single dose and multidose to a defined area of one knee of healthy subjects.

NCT ID: NCT01635972 Completed - Healthy Volunteers Clinical Trials

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Start date: June 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of a single dose of bupropion.

NCT ID: NCT01635946 Completed - Healthy Volunteers Clinical Trials

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin

Start date: August 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of a single dose of atorvastatin.

NCT ID: NCT01635023 Completed - Healthy Volunteers Clinical Trials

A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244

AZD6244Formula
Start date: July 2012
Phase: Phase 1
Study type: Interventional

Study in Healthy Males to Compare the White and Blue Formulations of AZD6244.

NCT ID: NCT01634191 Completed - Healthy Volunteer Clinical Trials

Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults

Start date: February 1, 2012
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the effects of age and sex on the pharmacokinetics and safety of a single oral dose of 30 mg apremilast in healthy adults.

NCT ID: NCT01634178 Completed - Healthy Volunteer Clinical Trials

Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults

Start date: February 1, 2012
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the effects of a high fat meal on the pharmacokinetics of a single dose of 30 mg apremilast in healthy adults.

NCT ID: NCT01634165 Completed - Healthy Volunteers Clinical Trials

A Study of LY2963016 in Healthy Participants

Start date: July 2012
Phase: Phase 1
Study type: Interventional

This study involves 2 single injections of LY2963016 and 2 single injections of Lantus. There will be at least 6 days between each injection. The study will compare LY2963016 to Lantus at two different doses. This study is approximately 10 weeks long, not including screening. Screening is required within 4 weeks of the start of the study.

NCT ID: NCT01632579 Completed - Healthy Volunteers Clinical Trials

A Single Dose Study of LY3023703 in Healthy Participants

Start date: June 2012
Phase: Phase 1
Study type: Interventional

This is a phase I study of LY3023703 in healthy participants. The purposes of this study are to look at safety, how well the study drug is tolerated, how much of the study drug gets into the blood stream, and how long it takes the body to get rid of it when given to humans. Information about any side effects that may occur will also be collected. Participants will remain in the study for approximately 3 months. This study is for research purposes only and is not intended to treat any medical condition.

NCT ID: NCT01632449 Completed - Healthy Volunteers Clinical Trials

Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.

Start date: July 2012
Phase: Phase 1
Study type: Interventional

This is an single-blind, single-center, two-period crossover, PK profile study. Each subject will be randomized to one of two treatment sequences. Both treatment sequences will be enrolled concurrently.

NCT ID: NCT01631422 Completed - Healthy Volunteer Clinical Trials

A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers

Start date: June 2012
Phase: Phase 1
Study type: Interventional

This single-center, open-label study will investigate the pharmacokinetics and elimination of a radiolabelled dose of RO4602522 in healthy male volunteers. The healthy male volunteers will receive a single oral dose of RO4602522.